Barclays’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.3M Buy
2,187,227
+763,450
+54% +$21.1M 0.01% 476
2025
Q1
$40.4M Buy
1,423,777
+227,838
+19% +$6.46M 0.01% 550
2024
Q4
$49.7M Sell
1,195,939
-336,873
-22% -$14M 0.01% 475
2024
Q3
$102M Buy
1,532,812
+193,059
+14% +$12.9M 0.03% 346
2024
Q2
$159M Buy
1,339,753
+146,856
+12% +$17.4M 0.05% 239
2024
Q1
$127M Buy
1,192,897
+84,733
+8% +$9.03M 0.04% 289
2023
Q4
$110M Buy
1,108,164
+163,264
+17% +$16.2M 0.04% 312
2023
Q3
$97.6M Buy
944,900
+34,008
+4% +$3.51M 0.06% 309
2023
Q2
$111M Buy
910,892
+256,295
+39% +$31.1M 0.07% 246
2023
Q1
$101M Sell
654,597
-813,653
-55% -$125M 0.05% 193
2022
Q4
$264M Sell
1,468,250
-120,454
-8% -$21.6M 0.12% 104
2022
Q3
$188M Buy
1,588,704
+399,454
+34% +$47.2M 0.21% 105
2022
Q2
$170M Sell
1,189,250
-124,917
-10% -$17.8M 0.1% 122
2022
Q1
$226M Sell
1,314,167
-1,987,952
-60% -$342M 0.18% 120
2021
Q4
$839M Buy
3,302,119
+2,047,118
+163% +$520M 0.31% 38
2021
Q3
$483M Buy
1,255,001
+657,299
+110% +$253M 0.22% 56
2021
Q2
$140M Buy
597,702
+185,034
+45% +$43.5M 0.07% 178
2021
Q1
$54M Sell
412,668
-190,618
-32% -$25M 0.03% 331
2020
Q4
$63M Sell
603,286
-189,310
-24% -$19.8M 0.03% 256
2020
Q3
$56.1M Buy
792,596
+356,811
+82% +$25.2M 0.03% 251
2020
Q2
$28M Buy
435,785
+322,685
+285% +$20.7M 0.02% 354
2020
Q1
$3.39M Buy
113,100
+94,258
+500% +$2.82M ﹤0.01% 1057
2019
Q4
$369K Sell
18,842
-9,163
-33% -$179K ﹤0.01% 2859
2019
Q3
$446K Sell
28,005
-14,125
-34% -$225K ﹤0.01% 2676
2019
Q2
$617K Sell
42,130
-30,701
-42% -$450K ﹤0.01% 2608
2019
Q1
$1.48M Buy
+72,831
New +$1.48M ﹤0.01% 1820